1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW

3. MARKET DYNAMICS
3.1. KEY DRIVERS
3.1.1. ADVANCED SEQUENCING METHODS LOWER THE COST OF SEQUENCING PROCEDURES
3.1.2. CONTINUOUS FUNDING BY THE MANUFACTURERS AND GOVERNMENTS IN GENOMICS
3.1.3. PREVALENCE OF CHRONIC DISEASES
3.2. KEY RESTRAINTS
3.2.1. LACK OF PROFESSIONALS WITH ADEQUATE KNOWLEDGE
3.2.2. SOCIAL AND ETHICAL ISSUES RELATED TO THE DATA PRIVACY

4. KEY ANALYTICS
4.1. IMPACT OF COVID-19 ON SEQUENCING REAGENTS MARKET
4.2. KEY MARKET TRENDS
4.3. PORTER'S FIVE FORCES ANALYSIS
4.3.1. BUYERS POWER
4.3.2. SUPPLIERS POWER
4.3.3. SUBSTITUTION
4.3.4. NEW ENTRY
4.3.5. INDUSTRY RIVALRY
4.4. SUPPLY CHAIN ANALYSIS
4.5. OPPORTUNITY MATRIX
4.6. VENDOR LANDSCAPE

5. MARKET BY TECHNOLOGY
5.1. NEXT-GENERATION SEQUENCING
5.2. SANGER SEQUENCING
5.3. THIRD-GENERATION SEQUENCING

6. MARKET BY REAGENT TYPE
6.1. SEQUENCING KITS
6.2. CONTROL KITS
6.3. LIBRARY KITS
6.4. TEMPLATE KITS
6.5. OTHER REAGENT TYPES

7. MARKET BY APPLICATION
7.1. ONCOLOGY
7.2. CLINICAL INVESTIGATION
7.3. AGRI GENOMICS AND FORENSICS
7.4. REPRODUCTIVE HEALTH
7.5. OTHER APPLICATIONS

8. MARKET BY END-USER
8.1. RESEARCH INSTITUTES
8.2. HOSPITALS AND CLINICS
8.3. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
8.4. OTHER END-USERS

9. GEOGRAPHICAL ANALYSIS
9.1. EUROPE
9.1.1. MARKET SIZE & ESTIMATES
9.1.2. KEY GROWTH ENABLERS
9.1.3. KEY CHALLENGES
9.1.4. KEY PLAYERS
9.1.5. COUNTRY ANALYSIS
9.1.5.1. GERMANY
9.1.5.2. FRANCE
9.1.5.3. UNITED KINGDOM
9.1.5.4. ITALY
9.1.5.5. RUSSIA
9.1.5.6. POLAND
9.1.5.7. BELGIUM
9.1.5.8. REST OF EUROPE

10. COMPETITIVE LANDSCAPE
10.1. KEY STRATEGIC DEVELOPMENTS
10.1.1. MERGERS & ACQUISITIONS
10.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
10.1.3. PARTNERSHIPS & AGREEMENTS
10.1.4. BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES
10.2. COMPANY PROFILES
10.2.1. AGILENT TECHNOLOGIES INC
10.2.2. ASURAGEN INC
10.2.3. BGI GENOMICS
10.2.4. BIO-RAD LABORATORIES INC
10.2.5. F. HOFFMANN-LA ROCHE
10.2.6. FLUIDIGM CORPORATION
10.2.7. ILLUMINA INC
10.2.8. LGC BIOSEARCH TECHNOLOGIES
10.2.9. MERCK KGAA
10.2.10. PACIFIC BIOSCIENCES OF CALIFORNIA INC
10.2.11. PERKINELMER INC
10.2.12. QIAGEN NV
10.2.13. TAKARA BIO INC
10.2.14. THERMO FISHER SCIENTIFIC INC
10.2.15. TRILINK BIOTECHNOLOGIES INC